Adults who underwent bariatric surgery and experienced diabetes remission but later regained weight and redeveloped the disease experienced weight loss and improvements in cardiometabolic parameters after 6 months of canagliflozin therapy, according to study data presented at the AACE Annual Scientific and Clinical Congress.
Source: Canagliflozin aids additional weight loss after refractory bariatric surgery